or
forgot password
  • cancer clinical trials in stanford, CA

  • Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Myelodysplastic Syndromes, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD)
    90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT)
    Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Mast-Cell
    CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
    Stanford University
    Stanford, California 94305
    Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia
    A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cardiovascular, Neurologic (Spine), and General Surgery
    Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
    Christopher Gardner
    Stanford, California 94305-5705
    Breast Cancer, Prostate Cancer
    A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Squamous Cell Carcinoma of the Head and Neck
    Treatment for Acute Graft-Versus-Host Disease
    Stanford Hospital and Clinics
    Stanford, California 94305
    Graft vs Host Disease, Immune System Disorders
    Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
    Stanford University Medical Center
    Stanford, California 94305-5408
    Hodgkin Disease
    Rituximab Post Autografting for Relapsed B-Cell Non-Hodgkin's Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Non-Hodgkin's Lymphoma
    An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain Edema, Brain Tumor
    XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain Edema, Brain Tumor
    Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Rectal Cancer, Colon/Rectal Cancer Rectal Cancer, Colon/Rectal Cancer
    Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Urologic Neoplasms
    A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Kidney Neoplasms
    Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer
    The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer
    Phase II Fludarabine, Cytoxan and FCCAM in Untreated B-Cell Chronic Lymphocytic Leukemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, B-Cell, Chronic, Leukemia, Chronic Lymphocytic Leukemia (CLL)
    Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Head and Neck Cancers
    A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Blood Cancer, Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS)
    Evaluation of Stereotactic Radiosurgery For Liver Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cholangiocarcinoma, Liver Cancer, Adenocarcinoma
    Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
    Stanford Cancer Center, Department of Urology
    Stanford, California 94305-5820
    Bladder Cancer
    Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    Stanford University
    Stanford, California 94305
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
    Stanford Cancer Center
    Stanford, California 94305-5824
    Acute Leukemia, Chronic Leukemia, Multiple Myeloma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Waldenstrom's Macroglobulinemia
    Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
    Leland Stanford Junior University
    Stanford, California 94305
    Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma
    Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Renal Cell Carcinoma
    Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Carcinoma, Small Cell, Small Cell Lung Cancer
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Neuroblastoma
    Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
    Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphocytic, Acute, Leukemia, Acute Lymphoid Leukemia (ALL)
    Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphocytic, Leukemia, Acute Lymphocytic Leukemia
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    Stanford Comprehensive Cancer Center
    Stanford, California 94305
    Acute Myelogenous Leukemia
    Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
    Stanford University Hospital and Clinics
    Stanford, California
    Malignant Ascites
    Study of XL647 Administered Orally Daily to Patients With Solid Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cancer
    A Follow-up Study of Women Evaluated and Treated for Infertility
    Stanford Medical Center
    Stanford, California 94303
    Infertility, Cancer
    High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplant
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT)
    Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Non-Hodgkin's Lymphoma
    Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Esophageal Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Esophageal Cancer
    Microarray Analysis of Gene Expression in Liver Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer
    Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
    Stanford University of Obstetrics and Gynecology
    Stanford, California 94305
    Ovarian Cancer
    A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms, Prostate Cancer
    Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphedema, Breast Cancer
    Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Graft vs Host Disease, Blood and Marrow Transplant (BMT)
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Stanford University
    Stanford, California 94305
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Rectal Cancer
    Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, B-Cell
    Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin, Lymphomas: Non-Hodgkin Cutaneous Lymphoma, Lymphomas: Non-Hodgkin Diffuse Large B-Cell, Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell, Lymphomas: Non-Hodgkin Mantle Cell, Lymphomas: Non-Hodgkin Marginal Zone, Lymphomas: Non-Hodgkin Peripheral T-Cell, Lymphomas: Non-Hodgkin Waldenstr Macroglobulinemia
    Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Metastatic Breast Cancer
    Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Metastatic Breast Cancer
    Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
    Stanford University
    Stanford, California 94305
    Epithelial Ovarian Cancer
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cytomegalovirus Infections
    Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
    Stanford University
    Stanford, California 94305
    Myelodysplastic Syndromes
    Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    ABT-751 With Chemotherapy for Relapsed Pediatric ALL
    Stanford University Medical Center
    Stanford, California 94305-5408
    Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia, Refractory Pediatric ALL
    Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
    Stanford University Medical Center
    Stanford, California 94305-5408
    Acute Lymphoblastic Leukemia
    Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Soft Tissue Sarcoma
    Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
    Stanford
    Stanford, California 94305
    Multiple Myeloma
    Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
    Stanford Cancer Center
    Stanford, California 94305-5824
    B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Multiple Myeloma
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    Stanford University
    Stanford, California 94305
    Venous Thrombosis, Pulmonary Embolism
    BG9924 in Combination With Methotrexate for Subjects With Active Rheumatoid Arthritis
    Stanford University
    Stanford, California 94305
    Rheumatoid Arthritis
    Extended Cessation Treatment for Teen Smokers
    Stanford University
    Stanford, California 94305
    Nicotine Dependence
    Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer